Henry Ford Health selected as one of only four U.S. academic health systems in Bayer’s strategic research network
Funding supports commercialization and sales growth expansion, targeting hundreds of new farms in the next 12 months Autonomy technology is designed to lower capital expenditures and...
Bayer’s first academic medical center alliance for clinical trial collaboration is designed to accelerate medical discovery and expand patient access to investigational therapies
One A Day®, the multivitamin and supplement brand from Bayer, has partnered with country superstar and five time Entertainer of the Year Luke Bryan to launch a limited edition multivitamin bottle featuring...
Advances key component of Crop Science division’s Five-Year Framework strategy Reinforces commitment to delivering trusted Roundup ® brands and glyphosate...
Collaboration focuses on small molecule discovery Bayer to leverage Iambic’s AI platform to address hard-to-drug targets Collaboration will strengthen Bayer’s research...
The Crop Science division of Bayer announced that Kacy Perry has been appointed the Country Division Head (CDH) for Crop Science Canada, effective July 1. In this role, she will lead 550+ employees working...
Bayer today announced the completion of the acquisition of Perfuse Therapeutics, Inc. As a result, Perfuse Therapeutics will now be fully integrated into Bayer. As announced previously ,...
Key Facts Campaign: Project DIY is a new campaign under Aleve’s recently launched Feel Aleve ® platform. Project DIY showcases how, when...
Key Facts: Bayer’s AMBELVIST ® (gadoquatrane) becomes the lowest-dose macrocyclic gadolinium (Gd)-based contrast agent (mGBCA) approved...